ID   M74
AC   CVCL_B4NP
DR   Wikidata; Q110433013
RX   Patent=US6444207;
RX   PubMed=2427436;
RX   PubMed=2460221;
RX   PubMed=3721623;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=US6444207;
RA   Schoemaker H.J.P., Carrano R.A.;
RT   "Immunotherapy of tumor with monoclonal antibody against the 17-1A
RT   antigen.";
RL   Patent number US6444207, 03-Sep-2002.
//
RX   PubMed=2427436;
RA   Gottlinger H.G., Johnson J., Riethmuller G.;
RT   "Biochemical and epitope analysis of the 17-1A membrane antigen.";
RL   Hybridoma 5 Suppl. 1:S29-S37(1986).
//
RX   PubMed=2460221;
RA   Fogler W.E., Klinger M.R., Abraham K.G., Gottlinger H.G.,
RA   Riethmuller G., Daddona P.E.;
RT   "Enhanced cytotoxicity against colon carcinoma by combinations of
RT   noncompeting monoclonal antibodies to the 17-1A antigen.";
RL   Cancer Res. 48:6303-6308(1988).
//
RX   PubMed=3721623; DOI=10.1002/ijc.2910380109;
RA   Gottlinger H.G., Funke I., Johnson J.P., Gokel J.M., Riethmuller G.;
RT   "The epithelial cell surface antigen 17-1A, a target for
RT   antibody-mediated tumor therapy: its biochemical nature, tissue
RT   distribution and recognition by different monoclonal antibodies.";
RL   Int. J. Cancer 38:47-53(1986).
//